Skip to main content
. 2017 Dec 6;97(2):255–266. doi: 10.1007/s00277-017-3167-7

Fig. 2.

Fig. 2

a Progression-free survival of BL patients treated with the LMB, BFM, HOVON, or CODOX-M/IVAC regimens. b Overall survival of BL patients treated with the LMB, BFM, HOVON, or CODOX-M/IVAC regimens. LMB, black line; BFM, red line; HOVON, green line; and CODOX-M/IVAC, blue line